TTelomere Therapeutics — Seed (estimated) · €1.5M
Telomere Therapeutics is a spin-off of CNIO and UAB, founded by Maria Blasco and Fàtima Bosch. It is developing a telomerase gene therapy for pulmonary and renal fibrosis. The first round of €1.5M was led by Invivo Ventures; a CDTI co-investment was reported separately.
LeadInvivo Ventures
RoundSeed (estimated)
Announced1 Dec 2020
CityMadrid · reported Barcelona
SectorHealthtech & Bio · Biotech
Source
I
I